Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna's updated COVID vaccine effective against 'Eris' variant in humans
05:59pm, Thursday, 17'th Aug 2023
Moderna said on Thursday an initial study data showed its updated COVID-19 vaccine to be effective against the "Eris" and "Fornax" subvariants in humans.
Moderna says new Covid vaccine was effective against Eris variant in early trial
05:35pm, Thursday, 17'th Aug 2023
Moderna's vaccine and new shots from Pfizer and Novavax are slated to roll out within weeks, pending potential approvals from the Food and Drug Administration.
Moderna says updated COVID vaccine effective against widely circulating Eris variant
04:45pm, Thursday, 17'th Aug 2023
Moderna Inc. said Thursday that preliminary clinical trial data show that its updated COVID-19 vaccine is effective against newer variants that are starting to circulate widely. The shot significantly
MRNA Stock Alert: Why Is Moderna Up 7% Today?
04:05pm, Thursday, 17'th Aug 2023
Who knew getting sick could make you richer? Today, investors in Moderna (NASDAQ: MRNA ) certainly feel that way, as MRNA stock shoots roughly 7% higher.
Can Moderna (MRNA) Diversify Beyond Its COVID-19 Jab Sales?
10:55am, Tuesday, 15'th Aug 2023
With COVID-19 vaccine sales declining, Moderna (MRNA) is accelerating the development of its non-COVID pipeline. It is gearing up for potential product launches over the next three years.
Stock screen spotlights 20 companies whose 2024 earnings estimates have risen most sharply
09:40am, Monday, 14'th Aug 2023
With another earnings season almost complete, it might be useful for investors to look further ahead. Each earnings season, we can see 70% to 80% of the S&P 500 “beating” consensus quarterly profi
Pfizer, Moderna and Novavax developing jab to combat new Covid strain
09:32am, Monday, 14'th Aug 2023
Three US pharmaceutical companies, Pfizer Inc (NYSE:PFE), Moderna Therapeutics Inc (NASDAQ:MRNA), and Novavax Inc, are gearing up to release updated Covid-19 vaccines this autumn. The new jabs are de
3 Pharma Stocks to Sell in August Before They Crash and Burn
08:52pm, Friday, 11'th Aug 2023
With pharmaceutical companies, it's all about the pipeline of new medications. Drugmakers, and their pharma stocks, are judged based on sales of current medications and potential sales of future presc
3 Healthcare Stocks to Sell in August Before They Crash and Burn
06:35pm, Wednesday, 09'th Aug 2023
Healthcare continues to lag in the broader market. Year to date, the Standards and Practices (S&P) 500 Health Care index is down 2% versus a 17% gain in the benchmark S&P 500 index.
Deutsche Bank Downgrades Moderna (MRNA)
01:42am, Saturday, 05'th Aug 2023
Fintel reports that on August 3, 2023, Deutsche Bank downgraded their outlook for Moderna (NASDAQ:MRNA) from Buy to Hold.
Moderna (MRNA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
12:02pm, Friday, 04'th Aug 2023
While the top- and bottom-line numbers for Moderna (MRNA) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to
Moderna, Inc. (MRNA) Q2 2023 Earnings Call Transcript
01:49pm, Thursday, 03'rd Aug 2023
Moderna, Inc. (NASDAQ:MRNA ) Q2 2023 Results Earnings Conference Call August 3, 2023 8:00 AM ET Company Participants Lavina Talukdar - Head, Investor Relations Stéphane Bancel - Chief Executive Offic
Moderna expects up to $4B in COVID-19 vaccine sales to private market in 2023
01:21pm, Thursday, 03'rd Aug 2023
Moderna said it expects up to $4 billion in sales of its COVID-19 shots to the private market during 2023, depending on U.S. vaccination rates.
Moderna (MRNA) Beats on Q2 Earnings & Sales, Raises '23 View
12:45pm, Thursday, 03'rd Aug 2023
Moderna (MRNA) beats expectations for earnings and sales. Management raises its product revenue guidance based on potential U.S. demand for COVID vaccines during the upcoming fall season.
Moderna shares up after hiking forecast on Covid-19 vaccine
11:30am, Thursday, 03'rd Aug 2023
Moderna stock is on the rise after the company hikes its full-year forecast on its Covid-19 vaccine. Yahoo Finance Live's Julie Hyman breaks down the story.
